286 related articles for article (PubMed ID: 28569194)
1. Severe child form of primary hyperoxaluria type 2 - a case report revealing consequence of GRHPR deficiency on metabolism.
Konkoľová J; Chandoga J; Kováčik J; Repiský M; Kramarová V; Paučinová I; Böhmer D
BMC Med Genet; 2017 May; 18(1):59. PubMed ID: 28569194
[TBL] [Abstract][Full Text] [Related]
2. Late diagnosis of primary hyperoxaluria type 2 in the adult: effect of a novel mutation in GRHPR gene on enzymatic activity and molecular modeling.
Levin-Iaina N; Dinour D; Romero L; Ron R; Brady RL; Cramer SD; Holtzman EJ
J Urol; 2009 May; 181(5):2146-51. PubMed ID: 19296982
[TBL] [Abstract][Full Text] [Related]
3. The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II.
Cramer SD; Ferree PM; Lin K; Milliner DS; Holmes RP
Hum Mol Genet; 1999 Oct; 8(11):2063-9. PubMed ID: 10484776
[TBL] [Abstract][Full Text] [Related]
4. Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2.
Knight J; Holmes RP; Milliner DS; Monico CG; Cramer SD
Nephrol Dial Transplant; 2006 Aug; 21(8):2292-5. PubMed ID: 16597637
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.
Cregeen DP; Williams EL; Hulton S; Rumsby G
Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635115
[TBL] [Abstract][Full Text] [Related]
6. Genetic basis of primary hyperoxaluria type II.
Webster KE; Cramer SD
Mol Urol; 2000; 4(4):355-64. PubMed ID: 11156703
[TBL] [Abstract][Full Text] [Related]
7. Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.
Pelle A; Cuccurullo A; Mancini C; Sebastiano R; Stallone G; Negrisolo S; Benetti E; Peruzzi L; Petrarulo M; De Marchi M; Marangella M; Amoroso A; Giachino D; Mandrile G
J Nephrol; 2017 Apr; 30(2):219-225. PubMed ID: 26946417
[TBL] [Abstract][Full Text] [Related]
8. Ethnic differences in GRHPR mutations in patients with primary hyperoxaluria type 2.
Takayama T; Takaoka N; Nagata M; Johnin K; Okada Y; Tanaka S; Kawamura M; Inokuchi T; Ohse M; Kuhara T; Tanioka F; Yamada H; Sugimura H; Ozono S
Clin Genet; 2014 Oct; 86(4):342-8. PubMed ID: 24116921
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperoxaluria type 2 in children.
Johnson SA; Rumsby G; Cregeen D; Hulton SA
Pediatr Nephrol; 2002 Aug; 17(8):597-601. PubMed ID: 12185464
[TBL] [Abstract][Full Text] [Related]
10. Modification of primers for GRHPR genotyping: avoiding allele dropout by single nucleotide polymorphisms and homology sequence.
Takaoka N; Takayama T; Miyazaki M; Nagata M; Ozono S
Urol Res; 2008 Dec; 36(6):297-302. PubMed ID: 18982322
[TBL] [Abstract][Full Text] [Related]
11. Glycolate oxidase deficiency in a patient with congenital hyperinsulinism and unexplained hyperoxaluria.
Clifford-Mobley O; Rumsby G; Kanodia S; Didi M; Holt R; Senniappan S
Pediatr Nephrol; 2017 Nov; 32(11):2159-2163. PubMed ID: 28752386
[TBL] [Abstract][Full Text] [Related]
12. Novel mutation in the GRHPR gene in a Chinese patient with primary hyperoxaluria type 2 requiring renal transplantation from a living related donor.
Lam CW; Yuen YP; Lai CK; Tong SF; Lau LK; Tong KL; Chan YW
Am J Kidney Dis; 2001 Dec; 38(6):1307-10. PubMed ID: 11728965
[TBL] [Abstract][Full Text] [Related]
13. Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association.
Valoti E; Alberti M; Carrara C; Breno M; Yilmaz Keskin E; Bresin E; Cuccarolo P; Açikgöz Y; Benigni A; Noris M; Remuzzi G; Mele C
Nephron; 2019; 142(3):264-270. PubMed ID: 30889567
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyproline metabolism in mouse models of primary hyperoxaluria.
Knight J; Holmes RP; Cramer SD; Takayama T; Salido E
Am J Physiol Renal Physiol; 2012 Mar; 302(6):F688-93. PubMed ID: 22189945
[TBL] [Abstract][Full Text] [Related]
15. Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2).
Webster KE; Ferree PM; Holmes RP; Cramer SD
Hum Genet; 2000 Aug; 107(2):176-85. PubMed ID: 11030416
[TBL] [Abstract][Full Text] [Related]
16. Late diagnosis of primary hyperoxaluria type III.
Richard E; Blouin JM; Harambat J; Llanas B; Bouchet S; Acquaviva C; de la Faille R
Ann Clin Biochem; 2017 May; 54(3):406-411. PubMed ID: 27742850
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic and functional analysis of human SLC26A6 variants in patients with familial hyperoxaluria and calcium oxalate nephrolithiasis.
Monico CG; Weinstein A; Jiang Z; Rohlinger AL; Cogal AG; Bjornson BB; Olson JB; Bergstralh EJ; Milliner DS; Aronson PS
Am J Kidney Dis; 2008 Dec; 52(6):1096-103. PubMed ID: 18951670
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of substrate specificity in human glyoxylate reductase/hydroxypyruvate reductase.
Booth MP; Conners R; Rumsby G; Brady RL
J Mol Biol; 2006 Jun; 360(1):178-89. PubMed ID: 16756993
[TBL] [Abstract][Full Text] [Related]
19. Primary hyperoxaluria in Coton de Tulear.
Vidgren G; Vainio-Siukola K; Honkasalo S; Dillard K; Anttila M; Vauhkonen H
Anim Genet; 2012 Jun; 43(3):356-61. PubMed ID: 22486513
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
